About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Week in review: Glaucoma diet, paralysis surgery, novel KPro

This week, a study suggests some low-carb diets may help combat glaucoma, an innovative reinnervation surgery for facial paralysis and CorNeat’s novel keratoprosthesis is cleared for clinical trials in Israel. Source: AAO

Posted on: Jul 24 2020
By: Saratoga Opthalmology
Leave a reponse

Guidance for managing noninfectious uveitis with immunomodulatory therapy during the COVID-19 pandemic

This article provides consensus guidelines to steer the treatment of patients with noninfectious uveitis during the COVID-19 pandemic. Source: AAO

Posted on: Jul 23 2020
By: Saratoga Opthalmology
Leave a reponse

Study unveils clinical course of TBK1-associated glaucoma

This study is the first to report the clinical features of glaucoma associated with a TANK binding kinase (TBK1) gene duplication. Source: AAO

Posted on: Jul 23 2020
By: Saratoga Opthalmology
Leave a reponse

Study unveils characteristics of firework-related ocular injuries

This study characterized firework-related injuries in the United States to determine specific actionable associations that could guide public policies and reduce the extent of ocular injuries. Source: AAO

Posted on: Jul 22 2020
By: Saratoga Opthalmology
Leave a reponse

Parental myopia tied to higher risk of early-onset myopia

This study investigated the association of parental myopia with refractive error and ocular biometry in multiethnic children aged 6 to 72 months. Source: AAO

Posted on: Jul 20 2020
By: Saratoga Opthalmology
Leave a reponse

Week in review: Cataract drops, liquid cornea, snappy shrimp

This week, an experimental eye drop for cataract snags an NEI grant, scientists develop a liquid-hydrogel alternative to corneal transplants and snapping shrimp prove they have the fastest eyes in the water. Source: AAO

Posted on: Jul 17 2020
By: Saratoga Opthalmology
Leave a reponse

Are immunosuppressive treatments safe during the COVID-19 pandemic?

This review highlights the current literature and best practice guidelines on the use of immunosuppression in the time of the COVID-19 pandemic. Source: AAO

Posted on: Jul 16 2020
By: Saratoga Opthalmology
Leave a reponse

Conjunctivitis may be the presenting sign of pediatric inflammatory multisystem syndrome

The authors described the characteristics of hospitalized children who developed pediatric inflammatory multisystem syndrome temporally associated with COVID-19. Source: AAO

Posted on: Jul 15 2020
By: Saratoga Opthalmology
Leave a reponse

First blepharoptosis drug gains FDA approval

The FDA has cleared a novel ophthalmic solution of oxymetazoline hydrochloride (Upneeq) for acquired blepharoptosis, making it the only approved therapy for the condition. Source: AAO

Posted on: Jul 14 2020
By: Saratoga Opthalmology
Leave a reponse

Laser interstitial thermal ablation leads to fewer and smaller visual field deficits

In this study, researchers assessed visual field deficits following laser interstitial thermal ablation for mesial temporal lobe epilepsy. Source: AAO